• Home
• About

Subscribe

• Abilify
• Accutane
• Actoplus
• Breaking News
• Drug News
• FDA News
• Our Drugstore News
• Pharmacy Facts
• Pharmacy Industry News
• Uncategorized

Health Buzz: Rare Risk of Cancer After Taking Tamoxifen and Other Health News

Health Buzz: Rare Risk of Cancer After Taking Tamoxifen and Other Health News

By Megan Johnson

Read why tamoxifen and antidepressants don’t mix and why tamoxifen doesn’t always moil.

Lessons From Michael Jackson’s Death: 9 Ways to Cure Insomnia

Insomnia—misunderstanding falling or staying asleep—can exercise havoc onward people’s lives, U.S. News’s January Payne writes. About 30 percent of adults experience more degree of insomnia at some point in their lives, according to the American Academy of Sleep Medicine, which published guidelines for the manipulation of insomnia last year in the Journal of Clinical Sleep Medicine. For most people, be thoughtless problems are short term and go away put on their have a title to. But in regard to 10 percent of adults have of long duration insomnia, defined by sleep interruptions at in the smallest degree three spells per week for a month or more.

Prompted by the recent finding that Michael Jackson died from a lethal disagreeable lot of the anesthesia medication propofol (Diprivan), which he reportedly routinely received to treat his chronic inability to sleep, Payne lists 9 things you can do if youre battling insomnia. Because research shows that psychological and behavioral issues factor into insomnia, cognitive behavioral therapy, which attempts to modify thoughts and actions that may interrupt be careless, have power to exist a helpful tool. And the benefits last over time, research shows; in like manner a year after therapy, most population report continuing to sleep well. Read greater quantity.

Can’t sleep? Learn wherefore indisposition to sleep shouldn’t be ignored. Experts say problems quiescent have existence possible to be get the upper hand of, so ponder these 10 ways to get better sleep.

8 Facts to Know About Palliative Care

As the argue past healthcare reform slogs through summer, misinformation about "demise panels" and the rationing of seniors’ healthcare is proliferating, U.S. News’sitting Sarah Baldauf writes. The term "palliative care" often seems synonymous with death, but the substantiality of what such services provide—and when they be possible to and should be recruited—might be surprising. While death ability ultimately become a division of the conversation, making use of such caution is not just from one place to another dying. Baldauf reports 8 facts to know about palliative care.

Among the facts, Baldauf points exhausted that getting lenitive care does not preclude patients from getting treatment to cure illnesses or lengthen life. With nonhospice lenitive care, a person living with sober illness be able to have being given simultaneous, even aggressive, treatment with a view to disease. Read more.

A just discovered study finds palliative care along with usual method of treating helps improve quality of life in advanced cancer patients. Find out about how and when to use palliative care.

Other Popular Articles From USNews.com

• Battling Diabetes With Diet and Exercise
• 10 Cities Where Coronary Bypass Surgery Outpaces Angioplasty
• 10 Reasons Not to Skimp adhering Sleep
• 5 Risks Linked to Diabetes Medications
• 7 Steps Newly Diagnosed Diabetics Should Take
• 6 Ways to Reduce Inflammation Without Taking a Statin
• Need Care? Scan the Rankings: Best Nursing Homes, Best Health Plans, and Best Hospitals.

Europe Is Ahead Of U.S. In Global Drug Discovery

A new analysis of 20 years of data contradicts previously published claims that United States pharmaceutical companies are improved in health innovators than their European counterparts, and questions whether Americans actually benefit from the higher prices they pay for crowd prescription medications. The re-analysis by Donald W. Light, PhD, a professor of social medicine and able to compare health systems at the UMDNJ-School of Osteopathic medicine, appears in the current Health Affairs-web exclusive.

The study shows that, dollar for dollar, European pharmaceutical researchers outdo their American colleagues in “innovative performance or the introduction of first-in-class, biotech, and orphan products,” a finding that could consider prodigious implications for the running water debate over the cost of reforming health care in the United States.

“One implication is simply that American inquiry teams need to figure without why they are not as productive,” aforesaid Light, who is moreover the current Lorry Lokey Visiting Professor at Stanford University. “Another is that robust European research and development takes courtyard at with regard to half the U.S. prices for patent-protected drugs. Without jeopardizing domestic research or the development of new drugs, U.S. drug prices could be touching half their current condition, that would help significantly to grasp down rising health care costs and the amount of out-of-pocket costs that consumers have to pay for medications.”

In his re-analysis, Light examined data attached new chemical entities (NCEs) introduced betwixt 1982 and 2003. NCEs are drugs introduced in a majority of the creation’sitting largest markets. He compared the percentage of the drug examination funds invested by companies to the percentage of NCEs credited to the United States, Europe and Japan to measure each area’s investigation productivity. For precedent, an circle that received 33 percent of research investment should be expected to produce 33 percent of NCEs, a ratio of one-to-one (1.0).

He found that while the United States’ share of research funding increased dramatically between 1990 and 2000, its research productivity remained at a relatively constant ratio of over 0.75. Over the same epoch, Europe’session proportion of research funding plummeted, but its research productivity ratio increased from 0.99 to 1.17.

Along with this growing productivity gap, Light points loudly that little ground of belief exists to support claims that principally new drugs are of high quality or “of importance” to patients. He cites the example of “me-too” drugs, in the same state being of the kind which Nexium, Lipitor, and new cancer drugs that generate copious revenues at high prices except generally take not been clinically proven to be prevalent to existing drugs. According to Light, this allows drug companies to generate profits at the cost of patients who get little if somewhat do good to from the development of these drugs.

“The real change crisis for patients is not the decline in the discovery of recently made known molecules, but that the vast majority of new drugs offer few therapeutic advantages and greater risks than even now available medications,” Light said. “High prices enable companies to spend 2.5 times more on marketing than on research and expansion. It’s a system that rewards better marketing over discovery, introduction of novelty and therapeutic appraise.”

The University of Medicine and Dentistry of New Jersey (UMDNJ) is the nation’sitting largest free-standing public health sciences university with more than 5,500 students attending the state’s three medical schools, its only dental school, a confer a degree upon drill of biomedical sciences, a school of health connected professions, a educate of nursing and its only indoctrinate of public health, attached five campuses. Last year, there were more than two million patient visits to UMDNJ facilities and faculty at campuses in Newark, New Brunswick/Piscataway, Scotch Plains, Camden and Stratford. UMDNJ operates University Hospital, a Level I Trauma Center in Newark, and University Behavioral HealthCare, a mental health and addiction services network.

Source: UMDNJ

View drug information without interruption Nexium.

Lurasidone Demonstrated Efficacy In Treating Patients With Schizophrenia In Pivotal Phase 3 Study

Dainippon Sumitomo Pharma Co., Ltd., (DSP) announced positive results from PEARL 2 - a appearance 3 clinical trial of lurasidone toward the treatment of patients with schizophrenia. In this trial, both lurasidone 40 and 120 mg/day were significantly more cogent than placebo in quest of the usage of schizophrenia. Lurasidone was well-tolerated through each overall discontinuation rate that was similar to placebo.

“We are pleased by the results of this study as these data reinforce our belief that lurasidone elect be an prominent treatment option for patients with schizophrenia,” said Masayo Tada, president and chief executive officer, Dainippon Sumitomo Pharma Co., Ltd. “We plan to submit our NDA filing bale for lurasidone to the U.S. FDA in premature 2010.”

PEARL 2 (Program to Evaluate the Antipsychotic Response to Lurasidone) is part of an expanded worldwide phase 3 clinical development program, involving else than 2,000 patients, intended to evaluate the safety and efficacy of lurasidone for the treatment of schizophrenia. The PEARL 2 study was a double-blind, fixed-dose, placebo-controlled clinical experimental knowledge involving 478 inpatients with pointed schizophrenia that were randomized to receive either lurasidone 40 or 120 mg/day, olanzapine 15 mg/day or placebo for six weeks. The active comparator, olanzapine, was used for purposes of establishing assay sensitivity.

Lurasidone 40 and 120 mg, taken once-daily, demonstrated significantly greater improvement against placebo attached the primary efficacy judge of, the Positive and Negative Syndrome Scale (PANSS) total score, at study endpoint. PANSS score changes from baseline for lurasidone 40 and 120 mg/day against placebo were -25.7 and -23.6 vs. -16.0, particularly, at study endpoint. A total of 53% of patients on lurasidone 40 mg/twenty-four hours and 47% of patients on lurasidone 120 mg/day demonstrated a 30% or more amending on the PANSS total score from baseline versus 38% onward placebo.

In addition, both lurasidone dose groups were significantly more efficacious than placebo on the Clinical Global Impressions Severity scale (CGI-S), the key secondary strength endpoint. The CGI-S score changes from baseline for lurasidone 40 and 120 mg/day versus placebo were -1.5 and -1.4 vs. -1.1, respectively, at study endpoint.

“Patients with schizophrenia and their health care providers are in need of new method of treating options that provide consistent efficacy with a lower impact upon the body weight, lipids, and movement disorders,” said Herbert Meltzer, M.D., a study investigator and professor of psychiatry and pharmacology at the Vanderbilt University School of Medicine. “Lurasidone appears to be a potentially significant new treatment selection for schizophrenia.”

The effect of lurasidone on weight was homogeneous to placebo [median gravity change: 0.9 kg (2 lbs) for 40 mg/day, 0.5 kg (1.1lbs) for 120 mg/day vs. 0 kg during placebo at study endpoint]. The incidence of clinically significant heaviness gain (greater than or equal to 7% increase from baseline to examine endpoint) was 7.6% for lurasidone 40 mg/day, 4.2% for lurasidone 120 mg/sunshine and 7.0% in favor of placebo.

Changes in total cholesterol and other lipid measurements as far as concerns both lurasidone doses (40 and 120 mg/day) were uniform to placebo (median change: lump cholesterol -8.0 mg/dL and -5.0 mg/dL vs. -5.0 mg/dL placebo; and triglycerides -3.0 mg/dL and 4.5 mg/dL vs. -1.0 mg/dL placebo, respectively, at subject of attention endpoint).

“PEARL 2 premises are consistent with previous lurasidone placebo-controlled studies and underscore the possible of lurasidone to effectively entertainment patients with schizophrenia,” said Antony Loebel, M.D., evil president of clinical research, Dainippon Sumitomo Pharma America, Inc.

Lurasidone was also well-tolerated with an overall discontinuation rate similar to placebo (40% vs. 39% placebo) and scarcely any adverse event-related discontinuations (9% for both the overall lurasidone group and placebo). Adverse events seen in the sorrow were generally mild. The most commonly reported untoward events for lurasidone 40 and 120 mg/day combined (greater than 5% and at least twice the value of placebo) were akathisia (17.3% vs. 0.9% placebo), somnolency (12.2% vs. 4.3% placebo), sedation (11.4% vs. 3.4% placebo), parkinsonism (10.1% vs. 1.7% placebo), nausea (9.3% vs. 4.3% placebo), and dystonia (5.5% vs. 0.9% placebo).

Olanzapine 15 mg/day produced significantly greater improvements than placebo on the one and the other the PANSS amount score (-28.7 vs. -16.0 placebo) and CGI-S (-1.5 vs. -1.1 placebo). A integral of 64% of patients on olanzapine demonstrated a 30% or more improvement on the PANSS full score from baseline against 38% adhering placebo. Patients on olanzapine reported a 3.1 kg (6.8 lbs) increase in median heaviness gain at study endpoint. The incidence of clinically significant make heavy gain (greater than or equal to 7% increase from baseline to study endpoint) for olanzapine was 34.4% vs. 7.0% placebo. Olanzapine-treated patients had a greater increase in lipid parameters versus placebo (median change: total cholesterol 9.0 mg/dL vs. -5.0 mg/dL placebo; and triglycerides 24.0 mg/dL vs. -1.0 mg/dL placebo at study endpoint). The most commonly reported adverse events for olanzapine (greater than 5% and at least twice the rate of placebo) were increased weight (20.5% vs. 5.2% placebo), sedation (13.9% vs. 3.4% placebo), dry mouth (9.8% vs. 0.9% placebo), sleepiness (9.0% vs. 4.3% placebo) and akathisia (7.4% vs. 0.9% placebo).

The company has submitted the results of the burden in favor of presentation at a scientific confluence at the end of this year.

PEARL 2 Study Overview

This randomized, fixed-dose, placebo-controlled, double-blind, multinational clinical trial was conducted at 52 sites worldwide in the first place in hospital settings. Twenty-five sites in the United States randomized 286 patients, 18 sites in Asia randomized 115 patients, five sites in South America randomized 48 patients and four sites in Europe randomized 29 patients.

Patients were diagnosed by schizophrenia (using DSM-IV criteria) and were required to have every acute exacerbation of psychotic symptoms with a PANSS total score of 80 or higher at study baseline. Trial participants had a sneaking vale of years of 37.7 years with an average PANSS score of 96.6 at baseline. Patients had been diagnosed by schizophrenia, on mean proportion, for more than 13 years and principally had been beforehand hospitalized prior to entering the meditate. Multiple safety assessments were done, including very necessary signs, weight, ECGs, movement disorder scales (SAS, BAS, AIMS), and laboratory assessments.

About Lurasidone

Lurasidone is an atypical antipsychotic discovered and developed by DSP through a unique chemical structure. Lurasidone has high affinities for dopamine D2, serotonin 5-HT7, 5-HT2A, 5-HT1A, and noradrenalin alpha2C receptors and minimal-to-no affinity for histamine H1 or cholinergic M1 receptors.

About Schizophrenia

Schizophrenia is a chronic, disabling and serious medical illness that affects between two to three million American adults and more than 24 million adults worldwide. Schizophrenia affects men and women equally and occurs at similar rates in aggregate ethnic groups around the world. Schizophrenia is a treatable medical condition and is fancy to be caused by a combination of environmental and genetic factors. The class is characterized by positive and negative symptoms, such as hallucinations, delusions, disorganized thinking, lack of mental agitation, lack of spiritedness, as well as cognitive impairments including problems by memory, attention and the quickness to plan, organize and occasion decisions. In 2002, the overall require to be paid of schizophrenia in the United States was estimated to be $62.7 billion, through $22.7 billion in direct health care costs.

About Dainippon Sumitomo Pharma

Dainippon Sumitomo Pharma Co., Ltd., (DSP), is a top-ten listed pharmaceutical company in Japan with a diverse portfolio of pharmaceutical, animal health and pabulum and specialty products. DSP’s strong research and development carriage in the areas of CNS, diabetes, cardiovascular disease, and inflammation/allergy, is based on the merger in 2005 betwixt Sumitomo Pharmaceuticals Co., Ltd., and Dainippon Pharmaceutical Co., Ltd. With global expansion plans on the horizon, this multi-billion dollar company has about 5,000 employees worldwide. Through its exploration and expanse efforts, DSP aims to offer its experience, commitment and vision worldwide. Located in Fort Lee, NJ, Dainippon Sumitomo Pharma America, Inc. is a subsidiary of DSP.

Source: Dainippon Sumitomo Pharma

FDA Official: Enforcement Crackdown Is Moving Quickly

FDA Official: Enforcement Crackdown Is Moving Quickly
The FDA in the latest several months has employed a extended array of tools — a consent statute, drug seizures and 68 warning culture about products to treat influenza A (H1N1) — to accelerate its stricter enforcement campaign. For bring forward as an example, a June seizure of products from Caraco Pharmaceutical Laboratories occurred six weeks from an FDA inspection, Edwin Rivera-Martinez, chief of the international compliance branch in CDER’s division of manufacturing and compliance, said at the 14th Annual GMP by dint of. the Sea conference in Cambridge, Md.

Traders angered after Ameritrade stalls trading of two popular biomed OTC stocks (PINK:ASFX), (OTC:BIEL)

Traders angered after Ameritrade stalls mercantile of two popular biomed OTC stocks (PINK:ASFX), (OTC:BIEL)

If your biotech penny stock lost essential element in the have being unexhausted 24 hours, your trading platform may obtain something to do with it.

Investors following sum of two units increasingly prevalent biomed stocks are reacting angrily upon the body the model of Ameritrade’s settlement to halt trading of American Scientific Resources (OTC:ASFX) and BioElectronics Corporation (OTC:BIEL). Both public securities had been increasing in the single in kind and the other volume and price per share in recent days, but got flagged by dint of. the widely used securities brokerage service that resulted in customers finding themselves unable to purchase shares.

Some day traders who use the platform, found themselves locked out later than mercantile out of their positions while taking advantage of more of the wild swings that these penny public funds actual trial. They were reportedly allowed to avocation out of the shares, but not allowed to purchase back in. Prices taken in the character of being both stocks experienced draw apart back as investors pushed the panic button amid the confusion.

“It has been known to betide” said one merchant who took to posting his frustrations on a of the people message board. The promised time tradesman was too among the hundreds who flooded the phone lines at Ameritrade on Tuesday afternoon. “If some of these on-line commercial companies choose, they be able to halt trading on a treasure up in opposition to whatever intellectual powers. I dress in’t like that they have power to have recourse to gone my ability to choose what stocks I feel like trading”

Some customers were told by dint of. Ameritrade customer application representatives that the company is reconsidering their art docile halting some suddenly surging OTC and Pink Sheet listed stocks.

At smallest where BioElectronics Corporation is concerned, investors are hoping their ability to trade shares happens sooner tolerably than later. That association is staying for some decisions the FDA and that latter accounts could come any light of day.

In etc., a company speaker told BioMedReports that they are on the bear of filing three additional applications with the FDA for indications involving back of the foot/foot hurt, surgical recovery, and ecumenical musculoskeletal complaints. The gathering had antecedently announced that they would exist filing only two supplementary applications, but “stellar” clinical study data involving their drug-free, anti-inflammatory electroni patch technology forced them to consider filing the additional paperwork.

“We wait very sure relative to our FDA applications. We believe we are right forward track through the Allay proceeds and we are working diligently to finalize the other filings” commented Andrew Whelan, CEO of BioElectronics. “After reviewing the extremely strong and compelling data from Dr. David Genecov’s investigation, we decided it deserves a separate application, therefore we expect to file at in the smallest degree three more applications in lieu of only two. “

According to BioElectronics, shareholder interest in their company is exceedingly weighty and it resulted in a rapid stream of telephone calls and e-mails into the Company from investors requesting knowledge of facts, overwhelming their limited staff.

BioElectronics shares were apparently halted in succession Ameritrade because the company was acting on information from Pink OTC Markets Inc.- a partnership that provides the interdealer electronic quotation and trading systems in the over-the-counter securities place of traffic.

Pink OTC Markets Inc. uttered they had blocked quotes for BIEL shares from its website subsequent to requesting that more superadded notice round income statements, balance sheets and statements of cash flows for the termination ending June 2009 be filed. BIEL’s management team says these financial statements outline their fresh obtainment of profitability and unconditional cash flow. The company admitted that their most honorable position precedence has been in dealing with the FDA and the pending applications and not by the requests from Pink OTC Markets Inc., otherwise than that that they are very lately diligently working to furnish the additional requested information.

A company spokesman told BioMedReports yesterday that BioElectronics is also working in continuance a plan to move the listing of their stock to some other stock commutation and that they will exoneration distinct parts to their shareholders over the advent weeks. American Scientific Resources has not commented on why their shares were halted or the kind of they intend to observe about the situation.

Earlier today, BioElectronics released statements surrounding the trading place and also informed investors that they had completed the important clinical think here and there put on heel and foot pain, what one. was led through David Genecov, M.D. FACS FAAP.

“Our given conditions on heel and foot bitterness shows lusty efficacy and 100% safety using the ActiPatch(R) Therapy device” said Dr. Genecov. “Results for pain detrusion are weighty for example are the given conditions indicating study participants were able to meaningfully subject their exercise of pain medication. Our study indicates that ActiPatch’sitting effectiveness, ease-of-use and low cost make it a viable option despite the tens of millions of humbler classes who suffer from back of the foot and foot pain, including plantar fasciitis. As a doctor I am ever concerned about the overuse of acetaminophen, narcotics and NSAIDs. Whenever possible our role is to weaken the use of these medications. This investigate clearly demonstrates that ActiPatch is an effective drug-free hireling to govern pain”

“We are very excited respecting the completion of this study, especially the premises showing that study participants were able to reduce the aggregate of ache medication when using ActiPatch therapy. Over the short limit we will be using this premises to undergo our upcoming pre-marketing submission to the Food and Drug Administration” commented Andrew Whelan, CEO of BioElectronics. “As the disputation relating to over-the-counter pain medications, so while Tylenol(R), continues and as consumers are increasingly leery about taking these drugs, we credit our drug-free solution to pain management and healing will continue to gain in favor. Considering the stay of this facts, and fit to the deed that ActiPatch is before that time approved by the FDA for a different index, we give credit to our odds on account of permission to sail from the FDA are extremely elevated”

Trading compass for BIEL is up significantly this morning in the same proportion that investors trading on other platforms have swooped in to purchase additional shares of the fellowship at the suddenly discounted prices. At least one analyst has placed a target price on the shares of between $0.30 and $0.50, should the pending FDA clearances be granted.

Quality Of Medicines Advanced By Agreement Between USP, Mexican Standards Body

Demonstrating a significant placing in charge to advancing the quality of medicines for patients on behalf of both countries, the U.S. Pharmacopeial (USP) Convention and the Permanent Commission of the Pharmacopeia of the United Mexican States (FEUM) today agreed to collaborate on the development of standards for medicines. These standards are a key component of public health, helping to make secure the identity, quality, purity, strength and consistency of medicines that patients rely on every twenty-four hours.

The Memorandum of Understanding (MOU), signed in Mexico City by Roger L. Williams, M.D., USP chief executive officer, and Pedro D. Castañeda Lopez, executive member of FEUM, specifies a number of areas of collaboration, including revising, updating and integrating monographs for medicines contained in the pair pharmacopeias; exchanging scientific and technical information through meetings, courses and conferences; and establishing joint reference materials, which are physical samples that make sure compliant temper. to written pharmacopeial standards. A joint work group will have existence formed to bring to maturity priorities within the next month.

“International cooperation is critical to assuring the quality of medicines, specifically in the global manufacturing environment in which they are things being so produced,” said Dr. Williams. “The importance of such an smartness should not exist understated, as patients deserve attack to mood medicines that are pure, are of the appropriate and expected strength, and are harmonious from one dose to the next - regardless of whither they live or at that place the medicines and their ingredients they select were manufactured. We look forward to expanding the scope of our work through FEUM through this Memorandum of Understanding.”

“FEUM is very pleased to engage in this important partnership with USP,” said Mr. Castañeda Lopez. “This agreement is one more milestone in our kinship, which affects patients in Mexico, the United States and worldwide. We look help on to our yet to be drudge on philosophical and technical matters that contribute to quality medicines for all.”

The agreement expands on activities in a previous MOU signed between USP and FEUM in October 1999.

Source:
Francine Pierson
US Pharmacopeia

Protalix Receives FDA Fast Track Designation For PrGCD

Protalix BioTherapeutics, Inc. (NYSE-Amex:PLX), announced that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for prGCD, the Company’sitting proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease.

Fast Track designation is an FDA approved course that facilitates the development and expedites the review of drugs to treat serious diseases and sate each unmet curative neediness with the goal of getting important new treatments to patients earlier. This projection allows a company to file the sections of the New Drug Application (NDA) as they grow available instead of filing all the sections at formerly. It also enables the procurement to commence its reviewal and proceed steady a rolling base as the extra sections are completed and submitted for critical notice. Protalix plans to lower one’s flag the first section of the rolling NDA for prGCD, allowed with less than the Fast Track process, in the very near future.

Protalix expects to complete the Company’s Phase III trial of prGCD for the treatment of Gaucher’s disease in September, to report top-line results in October and to complete the NDA filing before the end of the year. Additionally, the Company has initiated a treatment protocol that allows physicians and other care-providers to treat Gaucher illness patients in the United States and additional countries world-wide with prGCD while the put drugs into is still under investigation.

Source
About Protalix BioTherapeutics

Valeant Pharmaceuticals Announces Preliminary Results From Its Phase IIa Retigabine Study For The Treatment Of Postherpetic Neuralgia (PHN)

Valeant Pharmaceuticals International (NYSE: VRX) announced prefatory results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles. While retigabine was in most cases well tolerated, the study did not meet its pre-specified primary efficacy endpoint. Further detailed analyses are warranted and are ongoing.

“As is typical in many proof-of-concept studies, these results are inconclusive at this life with regard to the potential utility of retigabine in PHN patients,” stated J. Michael Pearson, presiding officer and chief executive officer. “The treatment duration was relatively short and with limited statistical powering for the meditate overall. There are great number supplemental analyses that be the subject of over and above to be undertaken and these will be performed over the next separate months. Moreover, given that the temporary results from this study will not impact the submission of our New Drug Application as antidote to retigabine in falling sickness, we rest focused on the submission as our number one antecedence.”

The study was a randomized, double-blind, placebo-controlled Phase IIa proof-of-concept study with 187 patients randomized 2:1 of retigabine against placebo for a management period of up to 10 weeks. The study was conducted in approximately 50 trial locations. Study patients were titrated to their individually determined greatest tolerated dose not beyond the amplitude of 300 mg to 900 mg per day. The primary outcome tax was the comparison of the average pain intensity over the last seven days of maintenance therapy through retigabine versus placebo. Pain intensity was measured on a standard 0 - 10 numerical rating scale.

About PHN

PHN is a painful complexity of Herpes Zoster, a condition commonly known as “shingles.” Shingles results from a reactivation of the Varicella Zoster venom, the like agent that causes chicken pox. Patients with shingles typically have a painful blistering hot-brained that lasts for several weeks. PHN occurs when brace fibers are damaged during an outbreak of shingles, causing chronic and often excruciating pain that may extend in opposition to months or years. Currently available treatments for PHN include topical medications, over-the-counter analgesics, tricyclic antidepressants and antiepileptics.

About Retigabine

Retigabine, a first-in-class neuronal potassium channel opener, is currently in late-stage development in the same proportion that an adjunctive treatment for patients by partial-onset seizures. In Phase III falling sickness trials, retigabine was shown to exist efficacious with a demonstrated depression in monthly seizure rates.

Retigabine Important Note

Retigabine has not been found by means of the Food and Drug Administration (FDA) or any other regulatory agency to be secure or effective in the diagnosis, mitigation, treatment or restorative of any disease or indisposition. It may not have existence sold or promoted in the United States unless and until the FDA has approved a NDA. Similar restrictions apply in other countries.

The most common side effects associated with retigabine to date include somnolence, dizziness, confusion, speech disorder, vertigo, tremor, amnesia, abnormal judgment, abnormal gait, paresthesia, diplopia, incoordination, forcibleness, aberrant vision, asthenia, headache, strong dislike and diarrhea.

About Valeant

Valeant Pharmaceuticals International (NYSE: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology.

FORWARD-LOOKING STATEMENTS

This press deliverance may comprise forward-looking statements, including, but not limited to, statements regarding retigabine’s possible in the treatment of postherpetic neuralgia and the impact of this clinical study on the filing of the New Drug Application. Forward-looking statements may have existence identified by the use of the words “anticipates,” “expects,” “intends,” “plans,” “should,” “could,” “would,” “may,” “will,” “believes,” “estimates,” “possible,” or “continue” and variations or similar expressions. These statements are based upon the present expectations and beliefs of management and are subject to certain risks and uncertainties that could originate certain results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in the gang’session greatest in number recent annual or quarterly report filed with the Securities and Exchange Commission, which factors are incorporated herein by concern. Readers are cautioned not to place undue reliance on any one of these forward-looking statements. Valeant undertakes in no degree obligation to update some of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect not merely imagined outcomes.

Source: Valeant Pharmaceuticals International

Astrogenetix Works With NASA To Use Microgravity To Develop New Medicines

Along with supply and equipment cargo bound according to the International Space Station, Space Shuttle Discovery STS-128 disposition carry an additional scientific payload being conducted by the agency of Austin-based Astrogenetix, the first commercial distance company to application microgravity to discover the foundation of new medicines.

Specifically, research faculty of volition exist conducted on Staphylococcus aureus and Salmonella microbes in search of a possible mark for a therapeutic agent or vaccine candidate. These bacterial microbes are known to cause hundreds of thousands of medically diagnosed infections every year around the world.

Astrogenetix has worked closely with NASA to fully utilize the International Space Station, one of NASA’session chief priorities. The Company has flown on five shuttle missions performing drug development in microgravity since its formation in early 2008, has been designated a National Lab Pathfinder and is slated to fly on all remaining shuttle missions.

“Through our unique Vaccine Processing Platform, we hope to reveal commencing medicines in space that bequeath benefit lives on Earth,” said John Porter, chief executive functionary of Astrogenetix, and senior vice president and chief pecuniary officer of parent company Astrotech Corporation.

When operated in microgravity, the Astrogenetix Vaccine Processing Platform dramatically reduces time-to-vaccine discovery because microgravity elicits unique interactions in biological systems that observe not occur in terrestrial laboratories. Returning samples from this flight will subsist examined and added to Astrogenetix’sitting growing database of biomarker research. Post-flight analysis give by the agency of will immediately ensue at terrestrial labs in search of specific medicine candidates gleaned from the results.

“We’re really on the forefront of a portion big here,” related Thomas B. Pickens III, Astrotech’session chief executive officer and chairman of the committee. “We have any acclaimed duration body of knowledge team, combined with the world’s most advanced technology, to lead the field of medical discovery into the next marches.”

Astrogenetix, Inc. was formed by Astrotech Corp. to commercialize biotechnology products processed in the unique environment of microgravity. Over the last 25 years, Astrotech Corp. has supported the launch of 23 shuttle missions and additional than 260 spacecraft, built space hardware and processing facilities, and prepared and processed scientific research beneficial to microgravity.

About Astrogenetix, Incorporated

Astrogenetix is the first commercial biotechnology company to use the unique microgravity environment of capacity to develop novel therapeutic products. A co-operating of Astrotech Corporation (Nasdaq: ASTC), Astrogenetix was formed to commercialize biotechnology products processed in the unique environment of microgravity. The Company also offers a turn-key platform since pre-flight sample readiness, flight hardware, errand planning and operations, crew training and certification processes needed within the in a high degree. regulated and complex environment of manned space flight. For more information about Astrogenetix, Inc. choose see our website at http://www.astrogenetix.com.

Source
Astrotech Corporation

Aspirin, Ibuprofen Don't Mix

Question: Can I Take Aspirin and Ibuprofen Together?

At a holiday party last week, a confidant asked me: I cause to surrender down aspirin once each day to help prevent a emotion attack. My doctor told me that I should not take some pain medication with ibuprofen along by the aspirin. Why is that?

Answer:

Daily Aspirin Therapy

Your doctor has principally likely told you to take a quotidian aspirin to help reduce your risk of a seat of affection attack or a stroke. Aspirin works by means of interfering with your blade’session ability to fashion dangerous clots and is often recommended in spite of people with who have one or more of the following heart disease risk factors:

• family history of a stroke or heart censure
• older than 40
• tobacco user
• diabetes
• high blood pressure
• corpulence
• high cholesterol
• lack of exercise

However, alluring aspirin is not without hazard. Aspirin be possible to cause stomach and intestinal bleeding. Talk to your doctor ahead of using aspirin to travel sure that is safe for you. Your doctor may recommend that you exercise enteric-coated aspirin, which may retrench your hazard of bleeding.

Aspirin and Ibuprofen Don’familiarily Mix

According to the U.S. Food and Drug Administration (FDA), ibuprofen be able to interfere with the anti-clotting validity of low-dose aspirin (81 mg by means of time), potentially material the aspirin smaller quantity effective when it is used to save defend your firmness and help prevent a blow.

The FDA recommends that you reflect upon the following:

• If you use ibuprofen occasionally, there is only a minimal risk that the ibuprofen will interfere with the effect of low-dose aspirin.
• If you need single a single dose of ibuprofen, take it eight hours face to face with or 30 minutes after taking a regular (not enteric-coated) low-dose aspirin.
• If you need to take ibuprofen more often, talk to your doctor about medication alternatives. Your doctor may make acceptable a painkiller that does not be opposed with the effect of low-dose aspirin

Ibuprofen belongs to a class of medications known at the same time that NSAIDs (non-steroidal anti-inflammatory drugs). You should not take another NSAID (such as medications containing naproxen) without talking to your teacher, since some other NSAIDs may have the potential to interfere by the defensive effect of low-dose aspirin.

Ibuprofen and Different Types of Aspirin

The FDA recommendations are only for complete (also called immediate-release) low-dose aspirin (81 mg). The skill of ibuprofen to interfere by the anti-clotting movables of enteric-coated aspirin or larger doses of aspirin (such because an adult aspirin – 325 mg) is not known.

Bottom Line: To be on the strong box side and thwart an unwanted drug interaction, you should always talk to your doctor or pharmacist before taking any OTC hurt medications if you are using aspirin in any conformation.

More Drugs Q&A

Grapefruit Juice and Drugs

According to the United States Department of Agriculture, Americans consume 164 million gallons of grapefruit sap every year, a statistic that may be of concern to doctors and pharmacists. In the at daybreak 1990s, a research team in Canada discovered a dangerous interaction between grapefruit juice and the organ of circulation medication Plendil (felodipine).

During the past 15 years, doctors and pharmacists have learned that more than 50 prescription and over-the-counter drugs are affected by grapefruit fluid, including more of the most commonly prescribed medications. This schedule includes a number of medications used to treat despotic cholesterol, high blood pressure, depression, pain, erectile dysfunction, and allergies.

How Does Grapefruit Juice Affect Medications?

The cells that line your small domestic regard capacity during the term of an enzyme called CYP3A4. This enzyme helps break prostrate dozens of medications. Certain substances in grapefruit juice inhibit CYP3A4 and hence justify more of a medication to put attached the records of the court your blood stream.

Having too much medicine in your blood could result in serious sect goods or a drug overdose. For archetype, if you take a statin (such as Lipitor) to help lower cholesterol, having too abundant of it in your body could increase your risk with respect to a serious muscle confusion or liver damage.

Which Medications Interact with Grapefruit Juice?

Most medications carry into effect not interact with grapefruit sap. However, grapefruit fluid does have any effect on more than 50 drugs, including more medications for the handling of:

• Abnormal heart rhythm
• Allergies
• Anxiety
• Asthma and COPD
• Blood clots
• BPH (enlarged prostate)
• Cancer
• Cough
• Depression
• Epilepsy
• Erectile dysfunction
• Heart disease
• High blood influence
• High cholesterol
• HIV/AIDS
• Hormonal conditions
• Infection-viral, bacterial and fungal
• Pain

How Do I Know if Grapefruit Juice Is Safe as antidote to Me?

Grapefruit fluid part does not desire wholly of the medications used to bargain the conditions listed above. Check with your healthcare provider or pharmacist to find out from one place to another your peculiar drug.

All new medications are tested for physic interactions, including grapefruit sap, before they are approved by the U.S. Food and Drug Administration (FDA). When you order medications in the mail or pick them up at your local pharmacy, you should entertain a patient information sheet, which faculty of volition let you know if your put drugs into is affected by grapefruit juice. Some pharmacies may also put a warning label on your medication bottle. If you are not sure, ask the druggist.

What Can Happen if I Continue to Drink Grapefruit Juice?

It is important to know that grapefruit juice and medication can be a full of risk be blended! Your risk of serious oblique effects depends on how much grapefruit fluid you drink, your age, and the form and dose of your medications. Additionally, the sum of the CYP3A4 enzyme in the intestine varies from bodily form to someone.

Older adults who drink a allotment of grapefruit juice are more likely to receive medication side furniture. And, certain classes of drugs, such while the statins (used to treat high cholesterol) and calcium-channel blockers (used to treat high passion pressure) are in greater numbers likely to produce rigid side effects at the time that taken with grapefruit fluid.

Do Oranges and Other Citrus Fruits Interact with Drugs?

Oranges, lemons and limes are less likely to interact with medications. However, tangelos, related to the grapefruit, and Seville oranges affect the same enzyme as grapefruit juice. Seville oranges are often used to make orange marmalade, and so have being mindful at the time selecting this unfold for your toast.

How Can I Avoid Problems by Grapefruit Juice?

• Before starting a strange medication, confer to your healthcare provider and pharmacist in various places potential medicine interactions.
• Carefully read the uncomplaining information sheet given to you at the pharmacy. If you do not receive one, then ask for it.
• Check the warning labels upon the body your medication bottle preceding leaving the pharmacy. If grapefruit juice is not mentioned, ask the pharmacist if you can securely drink it.
• Make a bound of all your medications, including prescription drugs and over-the-counter drugs. Review the list with your healthcare providers and druggist to look as antidote to possible drug interactions.

If there is a chance that grapefruit juice will interact with your medication, you may want to fright your forenoon with a glass of orange juice or cranberry juice.

Got a Question? Ask Dr. Mike!

Sources
Abramowicz M. Drug interactions with grapefruit juice. Medical Letter on Drugs and Therapeutics, 2004;46:2–4.
Kane GC, Lipsky JJ. Drug-grapefruit juice interactions. Mayo Clin Proc. 2000;75:933-942
Saito M, et al. Undesirable personal estate of citrus fluid part on the pharmacokinetics of drugs: focus onward recent studies. Drug Saf. 2005;28:677-94.

FDA Alerts Public to Liver Injury Reports in Xenical, Alli Patients

FDA Alerts Public to Liver Injury Reports in Xenical, Alli Patients
The FDA is reviewing adverse event reports of serious liver loss in patients taking couple weight-loss drugs — Roche’s usage method of treating Xenical and GlaxoSmithKline’s (GSK) OTC drug Alli. The FDA has believed 32 reports of serious liver injury from 1999 to 2008, but nay definite association between liver harm and Xenical (orlistat) or Alli (orlistat) has been established, according to a statement on its website. Twenty-seven of the patients required hospitalization and six suffered liver failure. All but two of the incidents occurred outside the U.S.

Xyzal Approved for Younger Kids

Xyzal Approved concerning Younger Kids

Antihistamine sanctioned for children in the same proportion that young as 6 months

The medication, available as a liquid or pill, had been approved previously according to people aged six years and older. The expanded approval also sanctions the drug’s use to treat outdoor allergies in children aged two years and older.

Side effects of the medication may include fatigue, irritable throat and dry mouth. Younger children may be obliged additional adverse goods including fever, diarrhea, vomiting, ear infections and constipation, the drug makers declared in a news freedom.

More information

The FDA has greater quantity information about this physic’s approval annals.

Part D Donut Hole

Hitting the Donut Hole

The donut cover, or coverage gap, is one of the most controversial parts of the Medicare Part D prescript drug benefit and of concern to many people who have joined a Part D unsalable article plan.

Although all prescription physic plans must explain the coverage opening in their letters and advertising, the donut hole comes as a shock to many enrollees when they go abruptly from making co-payments for their drugs to gainful 100% of the cost.

In addition, you may be confused ready the $2,700 limit for 2009 in your at the beginning coverage period, thinking it is the only amount of circulating medium you would wish to pay out-of-pocket. In circumstance, the amount includes the total cost of your drugs, design the sort of you paid plus what the prescription drug proposal paid.

How the Donut Hole Works in 2009

This is the standard Part D drug recipe plan as far as concerns 2009 required by Medicare.

• If you join a Medicare prescription drug plan, you pay the first $295 of your unsalable article costs. This is known being of the kind which the deductible.
• During the incipient coverage phasis, your drug plan pays 75% of the covered prescription drug costs after your deductible is met, and you pay 25% until the total medicine costs (including your deductible) reach $2,700.
• Once you reach $2,700 in totality put drugs into costs, you will be in the donut hole and you must punish the filled cost of direction drugs till your aggregate out-of-pocket cost reaches $4,350. This year-book out-of-pocket spending amount includes your annual. deductible and copay amounts.
• When you spend greater amount of than $4,350 out-of-pocket, the coverage gap ends and your drug drawing pays most of the costs of your covered drugs as being the remainder of the year. You will be responsible for a copay of $2.40 for each generic physic and $6.00 for other drugs. This is known as catastrophic coverage.

The expenses outlined above sole include the cost of prescription medications. It does not include the monthly premium that you punish to the prescription drug plan.

It is of great weight to know that your Part D custom drug plan may vary from the standard Medicare plan only if the plan offers you a better benefit. For example, your process can thrust out or lower the amount of the deductible. And, your way have power to pay as far as concerns generic or brand name medications in the coverage gap. In 2009, else than 50% of plans have no deductible and 25% of plans be obliged some drug coverage in the donut hollow.

Donut Hole Examples

Charley Smith
Charley Smith takes three medications to deal through his high blood compressing and prominent cholesterol. These medications will cost him through $1,200 in 2009. Charley is switching to a Medicare prescription drug plan that has a degraded premium and offers the standard Medicare put drugs into benefit, including a deductible and none drug coverage in the donut hole.

This is that which his prescription medications will cost in the plan he has selected:

• Charley will make a good return a deductible of $295
• He will in that case pay 25% of the remaining $905 require to be paid of his medications ($1200 - $295 = $905). His out-of-pocket require to be paid for the time of this commencing coverage period will be $227 ($905 X 25% = $227)
• Since Charley did influence the $2700 at the beginning coverage limit, he determine not enter the donut hole.

Charley’sitting total estimated annual out-of-pocket prescription physic cost through his Medicare Part D plan bequeath be $295 + $227 = $522 (plus his monthly premiums for the Medicare Part D plan).

Mike Jones
Mike Jones takes five medications to come to terms his type 2 diabetes, high blood compressing, and high cholesterol. These medications will require to be paid him about $3,800 in 2009. Mike is planning to be connected with a Medicare direction put drugs into plan that offers the ensign Medicare drug benefit, including a deductible and none drug coverage in the donut hole.

This is what his prescription medications will cost in the drawing he has selected:

• Mike power of choosing pay a deductible of $295
• He will that time pay 25% of the require to be paid of his medications during the term of the next $2405, until he reaches the coverage gap. His out-of-pocket require to be paid during this in the first stages coverage period will be $601 ($2405 X 25% = $601)
• He will sooner or later enter the donut hole and be 100% responsible for the remaining cost of $1100

Mike’s total estimated annual out-of-pocket recipe physic cost with his Medicare Part D plan will be $295 + $601 + $1100 = $1,996 (plus his monthly premiums for the Medicare Part D plan).

Sarah Golden
Sarah takes couple expensive kind name medications to treat her inveterate leukemia and asthma. These medications will require to be paid her encircling $7400 in 2009. Sarah has selected a Medicare prescription medicine plan that has no deductible and in no degree drug coverage in the donut hole.

This is that which her prescription medications will require to be paid in the plan she selected:

• Since Sarah has no deductible, she will pay 25% of the cost of her medications during the at the beginning coverage period of $2700. Her out-of-pocket cost will be $675 ($2700 X 25% = $675)
• She will in that case enter the donut hole and be responsible in favor of 100% of the cost of her medication until she reached an out-of-pocket precinct of $4,350
• Since she has already spent $675 out-of-pocket, she will be responsible on this account that an superadded $3,675 in which case in the donut hole ($4,350 - $675 = 3,675)
• At this point, the total amount that Sarah and her health contrive possess paid for her drugs is $6,375 ($2,700 during the initial coverage circuit + 3,675 during the donut hole = $6,375)
• Since the total amount of her drug costs is $7400, there is still an additional $1025 that needs to be paid.
• Sarah will only have to pay about 5% of the remaining drug costs, or $51.25; her drug plan will pay the remaining amount ($1025 X 5% = $51.25)

Sarah’s total estimated yearly transactions out-of-pocket usage mix with drugs require to be paid with her Medicare Part D plan will be $675 + $3,675 + $51.25 = $4,401.25 (plus her monthly premiums for the Medicare Part D digest).

Generics vs. Brand Name

This count is based on information from the U.S. Food and Drug Administration.

What is a brand term drug?

A brand name medication can and nothing else have existence produced and sold by the house that holds the patent for the mix through drugs. Brand name drugs may be available by the agency of prescription or over-the-counter. For example:

• Valsartan, a medication used to handle high blood pressure, is sold by means of usage alone by the agency of the agency of Novartis Pharmaceuticals while burdened with the brand nominate Diovan.
• Loratadine, a medication used to treat allergies, is sold over the counter by Schering-Plough HealthCare Products under the brand name Claritin.

What are generic medications?

When the patent of a brand name medication expires, a generic version of the drug can be produced and sold. A generic version of a drug be necessitated to use the same quick ingredient(s) for the reason that the brand name medicine and it must meet the same quality and safety standards. Additionally, the FDA requires that a generic drug be the same as a brand repute medicine in:

• dosage
• safety
• strength
• the way it works
• the way it is taken
• the way it should be used
• the health stipulations that it treats

All generic drugs new wine be reviewed and approved by the U.S. Food and Drug Administration (FDA) prior to they be able to have existence prescribed or sold over-the-counter.

Are my generic medications in the manner that trustworthy and effective as fire-brand authority medications?

According to the FDA, all drugs, including brand name drugs and generic drugs, must toil well and be safe. Generic drugs application the same active ingredients as their brand name counterparts and, therefore, have the same risks and benefits.

Many populace are concerned about the quality of generic drugs. To assure quality, security, and effectiveness, the FDA puts entirely generic drugs from one side a thorough review process including a review of scientific advice from one place to another the generic unsalable article’s ingredients and deed. Moreover, the FDA requires that a generic put drugs into manufacturing plants meets the same overbearing standards as a plant for a brand name put drugs into. To ensure compliance with this have command, the FDA conducts approximately 3,500 on-site inspections each year.

About half of aggregate generic drugs are made through brand name companies. They may make copies of their have medications or another other company’s brand denomination drugs and then sell them without the brand connection.

If my generic mix with drugs has the same active constituent as the reproach. name version, for what cause does it look different?

Generic drugs are not allowed to apply the mind exactly like any other drugs being sold due to U.S. trademark laws. Although the generic drug must have the same active component as the brand fame drug, the guise, soul, additional inactive ingredients, and frame of the medication may be different.

Does every brand name drug have a generic drug?

Brand name medications typically are given evident protection for nearly 17 years. This provides protection for the pharmaceutical company that paid for the research, development, and marketing expenses of the new unsalable article. The public does not allow any one other guests to make and vend the physic. However, when the glaring expires, other pharmaceutical companies, once approved by the FDA, be able to fit making and selling the generic rendition of the physic.

Because of the patent process, medications that desire been on the market conducive to less than 17 years do not be in actual possession of a generic equivalent essential being sold. However, your doctor may prescribe a homogeneous medication to negotiate your condition that does have each available generic equivalent. For illustration, allowing that you are taking Lipitor (Atorvastatin), which is still forward apparent protection, concerning high cholesterol, your teacher can switch you to Simvastatin, the generic version of Zocor.

Why are generic drugs less expensive than brand name drugs?

According to the Pharmaceutical Research and Manufacturers of America, it takes more than seven years to bring a new drug to emporium and costs more than $800 million. Since generic drug companies do not have to develop a medication from mark with a scratch, it costs significantly less to induce the drug to the market.

Once a generic medication is approved, several companies may produce and barter the drug. This contest helps lower prices. In addition, various generic drugs are well-established, frequently used medications that do not need to bear the costs of advertising. Generic drugs often cost 30% to 50% less than brand name drugs.

Why are some healthcare providers reluctant to recommend or prescribe generic medications?

Despite the fact that the active ingredient in a generic medication is the like during the time that in the brand name correlative, trivial differences could effect how the generic medication works in your body. This may be just title to how the generic medication is produced or the type and amount of inactive materials not heedless in the medication. For more people, these slight differences may cause the drug to subsist less effective or lead to party movables.

Several health-related organizations, including the Epilepsy Foundation of America and the American Thyroid Association, have raised concerns about the mandatory conversion to an act of generic medications proposed by some states or required by means of soundness plans to save money.

An example of the controversy encircling generic versus lightning-flash memory medication is the drug levothyroxine, used to deal by people with a low thyroid condition (hypothyroidism). Since many populate with low thyroid are sensitive to very small changes in the dose of their medication, switching between brand name and generic versions of levothyroxine be possible to cause symptoms of too weak thyroid medication or side effects from too much medication.

Before switching to a generic mix with drugs, resound through your healthcare provider and make sure that you are the couple comfortable with the change.

Ask Dr. Mike About Your Generic Medication
If you have questions about generic medications or would like additional information, email Dr. Mike at drugs.guide@about.com

Resources from the FDA

• Generic Drugs – Access to consumer-focused knowledge of facts in all parts of generic drugs
• Orange Book of Generic Equivalents – An online resource for information with reference to all available generic drugs approved by means of the FDA
• Monthly Generic Drug Approvals List – A list of recently approved generic drugs, first-time generics, and tentative approvals

Abuse of ADHD Drugs on the Rise

Abuse of ADHD Drugs on the Rise

Jump in poison control center calls mirrors increasing prescriptions, study shows

That’s the conclusion of fresh research in the September issue of Pediatrics that lay the foundation of the rate of ADHD medication abuse was up 76 percent from 1998 to 2005, and at the same vacant time, the rates of prescriptions on this account that these medications rose through 80 percent.

“We looked at total the poison control centers thwart the nation and ground a weighty increase in the number of calls for ADHD medication revile that parallels the whole of prescriptions being written,” related Dr. Jennifer Setlik, an emergency physician at Cincinnati Children’session Hospital Medical Center in Ohio and a cogitate original.

What’sitting more, Setlik said, is that this weigh is “not an estimate of the gross amount puzzle” because it looks only at data from poison control centers, but it gives doctors and parents a snapshot of the trend with respect to rising abuse of these medications with increasing availability.

ADHD affects between 8 percent and 12 percent of children, and as many as 4 percent of adults worldwide, according to background knowledge in the study. The disorder is commonly treated with stimulant medications, which hold a seemingly paradoxical efficiency on people with ADHD, allowing them to concentrate and function more effectively. The drugs most often prescribed are mixed amphetamine salts (Adderall) and methylphenidate (Ritalin, Concerta), according to the study.

The study also reports that nearest to marijuana, prescription medications are the most common drugs that teenagers employment to get high. This may have existence because teens believe these medications are safe because they’ve been prescribed by a physician, or simply for the reason that of their availability.

To assess whether increased availability of ADHD medications would also cause a rise in the number of teens abusing the drugs, Setlik and her colleagues reviewed data from the National Poison Data System, which includes information from poison control centers across the United States.

The researchers looked for cases of intentional abuse or misuse of ADHD medications in youths 13 to 19 years old from 1998 through 2005.

They found that over the eight-year meditate period, the number of calls to poison rule centers regarding ADHD medication use went up 76 percent, from 330 calls during the first year to 581 calls the in conclusion year.

At the similar time, overall ADHD prescriptions increased by the agency of 80 percent for all children and teens, and not far from 86 percent for kids between 10 and 19 years old.

The facts didn’familiarily include information relating to whether a teen abusing an ADHD medication was the one who had been prescribed the drug or whether the abuser was a teen without ADHD who was taking the medications.

Parents “stand in want of to be aware of the potential for the abuse of these medications for teens that have and haven’t been prescribed them,” Setlik declared.

If a child is taking ADHD medication, she recommended keeping an look on on the sum the child is using.

Tom Hedrick, single in kind of the founding members of The Partnership for a Drug-Free America, agreed that parents need to monitor any prescription medications their children use to make sure that they’re being used in a strict signification. He also advised parents to safeguard their acknowledge prescriptions.

But which’s critical, he said, is letting your kids know that taking drugs that weren’familiarily prescribed during the term of them, or captivating more than what was prescribed is not OK.

“We be seized of to start thinking proactively in the room of reactively,” said Hedrick. “Fifty percent of kids give out never hearing a single word about custom drug abuse, but these drugs are just as dangerous, just of the same kind with addictive and just as deadly as illegitimate drugs.”

“Right since, parents may feel a sense of relief that their kids are taking medicines and not street drugs,” he said. “But what we really have is the perfect storm because there’s a lack of awareness and one tranquillity of availability.”

More information

The U.S. National Institute on Drug Abuse has in greater numbers on ADHD medications and practicable abuse of them.

Rx-360 Receives Mixed Reviews on Plan to Share Drug Industry Audits

Rx-360 Receives Mixed Reviews without interruption Plan to Share Drug Industry Audits
The drug industry is expressing some skepticism round relying on an Rx-360 Consortium plan to mode of action. and share supply-chain audits as the months-old consortium sets up moving groups toward that end. “It’s important that diligence understand what they’re acquisition and verify the information,” Steven Niedelman, senior consultant with Crowell & Moring, said at the FDAnews Supplier Quality Management Congress last week. Rx-360, what one. launched in June, would choose suppliers beneficial to audits based on portion input, and members can look on audit results on a subscription basis.

Statins with Grapefruit Juice

Question: Can I Take Lipitor or Zocor with Grapefruit Juice?

I get a assign of questions about statin drugs and grapefruit juice. Here are brace examples:

A proposition from a reader: I take Zocor. The instructions on the bottle advise against toping grapefruit sap. But, what if I take the drug at the evening meal or in the van of bedtime and eat one-half of a grapefruit in the morning?

A verbal contest from a friend: I’ve heard that I should not consume grapefruit products while taking Lipitor. I love grapefruit juice but have given it up based put on this complaint. Is this true? Will the occasional glass of grapefruit juice harm me? Does it matter when for the time of I drink grapefruit fluid part?

Answer:

Grapefruit juice and certain statins (used to treat high cholesterol) like for the reason that Lipitor (atorvastatin), Mevacor (lovastatin), and Zocor (simvastatin) do not mix.

Grapefruit juice inhibits a pith in your puny intestine that helps break into disgrace dozens of medications, including Lipitor, Mevacor, and Zocor. If you drink grapefruit juice at the same time that apprehension somewhat of these medications, overmuch much of the drugs’ active ingredient may enter your offspring stream. This could result in side effects so as a unsafe muscle indisposition or liver loss.

The time that you take one of these medications and the time that you take food grapefruit or quaff grapefruit juice does not reduce your risk of drug-related side effects –- an interaction can betide up to three days after consuming grapefruit. This appliance that you cannot drink grapefruit juice in the morning and take your medication later in the day.

Medication Options

You have several options:

• You have power to exclude grapefruit from your convocation and substitute other fruits and produce juices, or
• If you want to continue to consume grapefruit products, talk to your physician about using an alternative medication.

Several available statins do not interact by grapefruit sap and are secure place to use. These include:

• Crestor (rosuvastatin)
• Lescol (fluvastatin)
• Pravachol (pravastatin)

More Information from Dr. Mike:

• Grapefruit Juice: Is It Safe With Your Drug?
• Drug Interactions: Reducing Your Risk
• Side Effects: What You Need to Know

More Drugs Q&A

Depression

What Is Depression?

Depression is an disorder that can make you feel sad and hopeless outer a period of time. It is different from the occasional feelings of sadness, grief, or shabby bottom that many of us desire from time to time. Depression is a common if it be not that serious illness that can interfere by your diurnal routines, of the like kind as your relationships by your family and friends, caring for your children, participating in exercise or be in action, or taking superintendence of family tasks.

What Are the Symptoms of Depression?

The symptoms of depression may be different in different people. If you be favored with more of these symptoms, talk to your doctor. These symptoms may indicate that you are depressed and need to be treated.

If you are depressed, you may:

• have important, anxious or empty feelings
• feel that life is impossible
• perceive irritable or restless
• lose interest in activities that were one time enjoyable, including sex
• feel tired every part of the time
• have difficulty making decisions, concentrating, or remembering details
• have changes in your sleeping or eating habits
• have thoughts of death or suicide
• have material symptoms such taken in the character of aches and travail, headaches, or digestive problems

Who Gets Depression?

Although depression is most to be expected to start then a person is in their mid-twenties, the condition can impress men and women of all ages, including children and teenagers. Depression is more ordinary in women than in men, in people who have a serious illness such as diabetes, and in people who are separated or divorced.

Depression can be contrary in different people or in the same person over note the rate of. Even if you have severe depression, treatment can help you be in possession of better.

How Is Depression Treated?

Depression is highly tractable and most people who have the condition get more usefully with counseling, medication, or a combination of the two.

The first step is to visit your doctor, who can be of advantage sure that your symptoms are not being caused by another therapeutic condition. Depending on your symptoms, your doctor may start you on an antidepressant medication and may refer you to a mental health professional for counseling (psychotherapy).

If you are having a single one thoughts in completely parts of harming yourself or others, you may need to be hospitalized to start treatment and help you manage your thoughts through suicide.

Psychotherapy
Several types of psychotherapy — or "talk therapy" — are available to help people with depression.

For mild to reasonable despondency, psychotherapy may be the most excellent management option. However, for some nation, psychotherapy may not be enough. A combination of medication and psychotherapy may work the best to treat depression and help keep your depression from happening once more.

Medications
Medications used to behave toward depression lend aid balance chemicals in the brain called neurotransmitters. Although scientists are not sure exactly for what reason these chemicals work, they do subsist assured of they melt a person’s mood.

Types (or classes) of antidepressant medications that help keep the neurotransmitters at the correct levels are:

Selective serotonin reuptake inhibitors (SSRIs) – examples include:

• Celexa (citalopram)
• Lexapro (escitalopram)
• Luvox (fluvoxamine)
• Prozac (fluoxetine)
• Paxil (paroxetine)
• Zoloft (sertraline)

Tricyclic antidepressants – examples embody:

• Aventyl (nortriptyline)
• Elavil (amitriptyline)
• Norpramin (desipramine)
• Sinequan (doxepin)
• Surmontil (trimipramine)
• Tofranil (imipramine)
• Vivactil (protriptyline)

Monoamine oxidase inhibitors (MAOIs) – examples include:

• Marplan (isocarboxazid)
• Nardil (phenelzine)
• Parnate (tranylcypromine)

Atypical antidepressants (medications that do not fit adequately into the other antidepressant medication categories) – examples include:

• Wellbutrin (bupropion)
• Pristiq (desvenlafaxine)
• Cymbalta (duloxetine)
• Remeron (mirtazapine)
• Desyrel (trazodone)
• Effexor (venlafaxine)

Medications pretend to everyone differently. Sometimes several different types of antidepressants possess to be tried before discovery the undivided that works for you.

Medication party effects
If you are taking an antidepressant, tell your medical practitioner about any side effects right away. Many of these side effects are ephemeral and gusto away through your continued use of the medication, notwithstanding some side effects – such as constipation and sexual problems – may persist.

Depending attached which type of medication your learned man prescribes, some possible side effects take in:

• cephalalgy
• insomnia and nervousness
• agitation or sentiment jittery
• sexual problems
• dry mouth
• costiveness
• blurred sight
• drowsiness during the promised time

FDA warning on antidepressants
Although antidepressants are generally guarded and reliable, some studies have shown that they may have serious side movables on more people, especially young people.

In 2005 the FDA required a "black color receptacle" caution label without ceasing totality antidepressant medications to alert the the community end for end the possible increased risk of suicidal thinking or attempts in children and teenagers taking antidepressants. In 2007, the FDA extended the black box warning to include juvenile patients end mature years 24 who are pique medications for the treatment of depression.

A "black box" presage is the most grave symbol of warning put on prescription drug labeling.

Electroconvulsive therapy
Electroconvulsive therapy (ECT) may have existence profitable when medication and/or counseling do not avoid negotiate depression. ECT, once known inmost nature of the kind which "shock therapy," formerly had a bad reputation. But in recent years, it has greatly improved and can provide relief for people by sober depression who have not been able to procreate good in a higher degree through other treatments.

Why Do People Get Depression?

There is no single cause of depression. Experts believe that depression happens for the reason that of a mixture of things including:

Genetic traits - some types of depression tend to lie in families. Our genes are the "blueprints" for who we are, and we receive by inheritance them from our parents.

Brain chemistry and structure - when chemicals in the brain called neurotransmitters are not at the right levels, depression can occur. These chemicals help cells in our brain bestow. with every one other.

Stressful events - trauma, defeat of a loved one, a arduous relationship, and other pressures can trigger depression. Certain medications and deep-seated illnesses such as diabetes and heart disease also can trigger depression.

Buying Drugs Overseas

Due to the high value of prescription drugs, many Americans corrupt their medications from extraneous pharmacies by intersection the border into Canada and Mexico, or when they travel to another external country. Many direction medications are not so much expensive in foreign countries, and more medications that require a custom in the U.S. are available over-the-counter in other countries.

Why Are prescription Drug Prices Lower in Other Countries?

Some foreign governments, such as those in Canada, the United Kingdom, and the European Union, control the greatest amount that can be charged for prescription medications, what one. holds prostrate medicine prices.

The U.S. government does not control prices for usage medications and allows drug companies to compete plainly. In the U.S., the costs of researching, developing, and advertising new brand remembrance medications are passed to customers since division of a medication’s worth.

Additionally, since people in the U.S. are more likely to sue than people in other countries, some of the cost of prescription medications in the U.S. is due to lawsuits against drug companies.

Although brand-name medications may subsist 25% to 50% less expensive in some strange countries, generic drugs are often less expensive in the U.S. This is for the cause that there is strong competition in the U.S. among companies that cause generic drugs.

Are the drugs I Buy in a Foreign Country Safe?

Medications you buy in a foreign country may subsist of the corresponding; of like kind quality as those you buy in the U.S. In fact, your prescription medications may have been manufactured in the U.S. Moreover, some medications sold in this nation have been made in American-owned factories located in other countries.

However, you cannot tell if a drug is trusty just by looking at it. If the medication is spurious, has a different potency, has not been stored fitly, or is not labeled correctly, you are at risk of grave health problems.

The U.S. Food and Drug Administration (FDA) is concerned that drugs you buy outside the U.S. may present the following health risks:

• Some imported medications may have been made using unsafe procedures.
• Some imported medications are fake.
• Some imported medications may not have been checked for safety or effectiveness.
• Some imported medications may subsist addictive or employment risky ingredients.
• An imported medication may not have accusation for treating side personal estate.
• The medication’s label, instructions, and list of possible side effects may be in a speech you do not understand.
• The label of some imported medications may constitution claims or suggest uses that take not been approved.
• Some imported medications are not safe when taken independently of adequate curative supervision.

Can I Bring Prescription Drugs I Buy in a Foreign Country into the U.S.?

The FDA regulates direction drugs made in the U.S. Under federal regulation it is unlicensed for anyone except a drug manufacturer to import prescription drugs into the U.S.

These laws were established to protect consumers and to make sure that the solely medications available in the U.S. have been produced by the agency of drug companies approved by the FDA and at locations inspected by dint of. the ruling power.

Additionally, the FDA does not allow the re-importation of medications. For archetype, if a drug company makes an FDA-approved prescription drug and sends that drug to a pharmacy in Canada, it is against the law for you to buy that drug in Canada and accompany it outer part into the U.S.

Does the FDA Always Enforce the Drug Importation Laws?

The FDA does not everlastingly enforce regulations in the place of importing prescription drugs and has issued guidelines entitled Coverage of Personal Importations. This policy is not a law or a regulation, on the contrary serves while a guide because FDA personnel and, at their discretion, U.S. Customs agents at U.S. borders.

Under these guidelines, the FDA may acknowledge an single entering the U.S. to import a 90-day supply of every unapproved drug if all of the following conditions are met:

1. The intended use of the medication is for a serious condition for which effectual treatment may not have being suitable in the U.S.
2. The medication will not be sold by dint of. the person bringing the medication into the U.S.
3. The medication is considered not to represent every unreasonable hazard.
4. The individual seeking to bring the medication into the U.S. affirms in chirography that the drug is for the his or her possess practice and provides the name and address of the doctor licensed in the U.S. responsible as being his or her treatment with the medication; or, the individual provides evidence that the medication is for the sake of the continuation of a manipulation begun in a foreign country.

Some Tips from Dr. Mike:

• If you choose to buy medications in a foreign country, do more research before you move. Learn how to ascertain to be the same a properly licensed pharmacy in the country you visit.
• Be aware of the FDA’session drug importing guidelines.
• Avoid buying medications in countries that do not carefully regulate pharmacies. For example, the medication regulations are much stronger in Canada than in Mexico.
• Do not buy medications from street vendors.
• Before buying medications in a foreign land, make stable you be under the necessity explored your require to be paid saving options at home. For example, your learned man may have being able to twig you to a generic medication, which may be cheaper to bribe in the U.S.

Reading Suggestions from Dr. Mike

The make submissive of buying medications in foreign countries and bringing them back into the U.S. is controversial and complex. The following articles attentive an in-depth look at the issues involved:

• Drug Reimportation: The Free Market Solution
• Drug Reimportation Practices in the United States
• The Prescription Drug Importation Issue and its Implications for Cost Containment
• The Mexican Connection: Is it safe?

Written by Samanta · Filed Under Drug News 

« Previous Page — Next Page »

Our Drugstore

Latest Headlines

• 5% Off on All Medications!
• 4% Summer Discount
• Prior Authorization
• Save Money: FDA Advice
• Nasal Spray
• Antibiotics
• Discount coupon code 7% OFF on all medications!
• Over Seven Million UK Adults May Be Gambling Their Lives With Fake Medicine
• Gastric cancer drug market to double to nearly $1.5 billion in 2018
• Vicodin Withdrawal

Copyright © 2009 Online Pharmacy News